Cannabis
High Tide Subsidiary Blessed CBD Launches Sales of Hemp-derived CBD Products on Amazon UK
High Tide Inc. (“High Tide” or the “Company“) (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), a leading retail-focused cannabis company with bricks-and-mortar as well as global e-commerce assets, announced today that its subsidiary, Blessed CBD (“Blessed“), has begun sales of its premium hemp-derived CBD products on Amazon in the United Kingdom (“Amazon UK“). A range of Blessed CBD products, including gummies, capsules, and balms are now available on Amazon UK, and the remaining Blessed CBD products will be listed in the coming days. All Blessed products qualify for next-day delivery through Amazon Prime. Blessed also intends to list any future SKUs that it may add to its product lineup on the Amazon UK platform.
As with all other CBD retailers who are listed on Amazon UK, Blessed was invited by Amazon themselves to join the platform as a seller of CBD. Retailers that sell CBD through Amazon UK are required to have received Novel Foods Authorization from the United Kingdom’s Food Standards Agency as well as pass compliance checks conducted by Amazon.
“The listing of Blessed CBD products on Amazon UK represents a fantastic growth opportunity for Blessed and High Tide. Amazon is unmatched as a global online marketplace, and by joining their platform in the UK, we are broadening Blessed’s reach and making our products accessible for many more consumers,” said Raj Grover, President and Chief Executive Officer of High Tide. “Today’s announcement is another example of the strength of High Tide’s diversified international cannabis ecosystem, as we are able to keep growing our presence and customer bases even in jurisdictions where cannabis is not yet legal. As we further execute on our international strategy, we will continue to explore new and innovative distribution channels for our products, as well as additional markets where we can expand into through our existing and rapidly-expanding ancillary cannabis brand portfolio,” added Mr. Grover.
Cannabis
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
Cannabis
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
Cannabis
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
transfer1 week ago
IMC to transfer its Oranim Pharmacy shares back to the seller
-
Cannabis1 week ago
Right on Brands Announces Major Product Line Expansion via HONEY® Brands
-
Cannabis7 days ago
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
-
Cannabis1 week ago
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
CCELL®2 weeks ago
CCELL Launches Environmentally Conscious Eco Star AIO Vaporizer
-
Innocan3 days ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf4 days ago
Curaleaf Completes Acquisition of Northern Green Canada
-
Cannabis3 days ago
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care